Sinphar Pharmaceutical Co (TPE:1734) Price-to-Operating-Cash-Flow : 9.96 (As of Dec. 13, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Sinphar Pharmaceutical Co Price-to-Operating-Cash-Flow?

As of today (2024-12-13), Sinphar Pharmaceutical Co's share price is NT$29.95. Sinphar Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was NT$3.01. Hence, Sinphar Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 9.96.

The historical rank and industry rank for Sinphar Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

TPE:1734' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.02 Med: 21.87 Max: 203.11
Current: 10.02

During the past 13 years, Sinphar Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 203.11. The lowest was 10.02. And the median was 21.87.

TPE:1734's Price-to-Operating-Cash-Flow is ranked better than
82.77% of 296 companies
in the Biotechnology industry
Industry Median: 25.83 vs TPE:1734: 10.02

Sinphar Pharmaceutical Co's Cash Flow from Operations per share for the three months ended in Sep. 2024 was NT$1.09. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was NT$3.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sinphar Pharmaceutical Co was 79.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 26.40% per year.

During the past 13 years, Sinphar Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 26.40% per year. The lowest was -34.30% per year. And the median was -6.50% per year.

Sinphar Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Sinphar Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinphar Pharmaceutical Co Price-to-Operating-Cash-Flow Chart

Sinphar Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

35.47

35.77

13.09

19.25

Sinphar Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															17.75	19.25	14.40	16.09	10.89

Competitive Comparison of Sinphar Pharmaceutical Co's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Sinphar Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinphar Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinphar Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sinphar Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.

Sinphar Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation

Sinphar Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	29.95	/	3.006
	=	9.96

Sinphar Pharmaceutical Co's Share Price of today is NT$29.95.
Sinphar Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Sinphar Pharmaceutical Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sinphar Pharmaceutical Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinphar Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinphar Pharmaceutical Co Ltd (TPE:1734) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269

Website

https://www.sinphar.com

Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.

Sinphar Pharmaceutical Co Headlines

No Headlines